| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |